Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Validation of the new consensus criteria for the diagnosis of corticobasal degeneration.

Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):925-9. doi: 10.1136/jnnp-2013-307035. Epub 2014 Feb 12.

2.

Neuropathology training worldwide-evolution and comparisons.

Del Bigio MR, Hainfellner JA, McLean CA, Powell SZ, Sikorska B, Takahashi H, Weis J, Xuereb JH.

Brain Pathol. 2014 Apr;24(3):285-98. doi: 10.1111/bpa.12104.

PMID:
24251639
3.

Pathogenic mitochondrial tRNA point mutations: nine novel mutations affirm their importance as a cause of mitochondrial disease.

Blakely EL, Yarham JW, Alston CL, Craig K, Poulton J, Brierley C, Park SM, Dean A, Xuereb JH, Anderson KN, Compston A, Allen C, Sharif S, Enevoldson P, Wilson M, Hammans SR, Turnbull DM, McFarland R, Taylor RW.

Hum Mutat. 2013 Sep;34(9):1260-8. doi: 10.1002/humu.22358.

4.

Neuropathological correlates of falling in the CC75C population-based sample of the older old.

Richardson K, Hunter S, Dening T, Xuereb JH, Matthews FE, Brayne C, Fleming J; Cambridge City over-75s Cohort (CC75C) Study Neuropathology Collaboration.

Curr Alzheimer Res. 2012 Jul;9(6):697-708.

PMID:
22471864
5.

The relationship between clinical and pathological variables in Richardson's syndrome.

Schofield EC, Hodges JR, Bak TH, Xuereb JH, Halliday GM.

J Neurol. 2012 Mar;259(3):482-90. doi: 10.1007/s00415-011-6205-8. Epub 2011 Aug 12.

PMID:
21837549
6.

Altered levels of glutamatergic receptors and Na+/K+ ATPase-α1 in the prefrontal cortex of subjects with schizophrenia.

Corti C, Xuereb JH, Crepaldi L, Corsi M, Michielin F, Ferraguti F.

Schizophr Res. 2011 May;128(1-3):7-14. doi: 10.1016/j.schres.2011.01.021. Epub 2011 Feb 24.

PMID:
21353485
7.

Clinical phenotypes in autopsy-confirmed Pick disease.

Piguet O, Halliday GM, Reid WG, Casey B, Carman R, Huang Y, Xuereb JH, Hodges JR, Kril JJ.

Neurology. 2011 Jan 18;76(3):253-9. doi: 10.1212/WNL.0b013e318207b1ce.

PMID:
21242493
8.

Clinical comparison of progressive aphasia associated with Alzheimer versus FTD-spectrum pathology.

Xiong L, Xuereb JH, Spillantini MG, Patterson K, Hodges JR, Nestor PJ.

J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):254-60. doi: 10.1136/jnnp.2010.209916. Epub 2010 Sep 14.

PMID:
20841368
9.

Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe.

Mukaetova-Ladinska EB, Xuereb JH, Garcia-Sierra F, Hurt J, Gertz HJ, Hills R, Brayne C, Huppert FA, Paykel ES, McGee MA, Jakes R, Honer WG, Harrington CR, Wischik CM.

ScientificWorldJournal. 2009 Dec 16;9:1463-75. doi: 10.1100/tsw.2009.151.

10.

Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases.

Hodges JR, Mitchell J, Dawson K, Spillantini MG, Xuereb JH, McMonagle P, Nestor PJ, Patterson K.

Brain. 2010 Jan;133(Pt 1):300-6. doi: 10.1093/brain/awp248. Epub 2009 Oct 5.

PMID:
19805492
11.

Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains.

van Eersel J, Bi M, Ke YD, Hodges JR, Xuereb JH, Gregory GC, Halliday GM, Götz J, Kril JJ, Ittner LM.

J Neural Transm (Vienna). 2009 Oct;116(10):1243-51. doi: 10.1007/s00702-009-0293-y. Epub 2009 Aug 20.

PMID:
19693433
12.

Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study.

Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH, Paykel E, Mukaetova-Ladinska EB, Huppert FA, O'Sullivan A, Dening T; Cambridge City Over-75s Cohort Cc75c Study Neuropathology Collaboration.

J Alzheimers Dis. 2009;18(3):645-58. doi: 10.3233/JAD-2009-1182.

PMID:
19661624
13.

Is the pathology of corticobasal syndrome predictable in life?

Shelley BP, Hodges JR, Kipps CM, Xuereb JH, Bak TH.

Mov Disord. 2009 Aug 15;24(11):1593-9. doi: 10.1002/mds.22558.

PMID:
19533751
14.

Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.

Pereira JM, Williams GB, Acosta-Cabronero J, Pengas G, Spillantini MG, Xuereb JH, Hodges JR, Nestor PJ.

Neurology. 2009 May 12;72(19):1653-60. doi: 10.1212/WNL.0b013e3181a55fa2.

15.

The neural basis of semantic memory: evidence from semantic dementia.

Davies RR, Halliday GM, Xuereb JH, Kril JJ, Hodges JR.

Neurobiol Aging. 2009 Dec;30(12):2043-52. doi: 10.1016/j.neurobiolaging.2008.02.005. Epub 2008 Mar 25.

PMID:
18367294
16.

High grade glioma: imaging combined with pathological grade defines management and predicts prognosis.

Burnet NG, Lynch AG, Jefferies SJ, Price SJ, Jones PH, Antoun NM, Xuereb JH, Pohl U.

Radiother Oncol. 2007 Dec;85(3):371-8. Epub 2007 Nov 26.

PMID:
18035440
17.

Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia.

Corti C, Crepaldi L, Mion S, Roth AL, Xuereb JH, Ferraguti F.

Biol Psychiatry. 2007 Oct 1;62(7):747-55. Epub 2007 May 24.

PMID:
17531207
18.

Sporadic malignant nerve sheath tumour of the oculomotor nerve.

Santarius T, Chia HL, Xuereb JH, Kirollos RW.

Acta Neurochir (Wien). 2007 Jun;149(6):617-22; discussion 622. Epub 2007 May 21.

PMID:
17514351
19.

Nuclear imaging can predict pathologic diagnosis in progressive nonfluent aphasia.

Nestor PJ, Balan K, Cheow HK, Fryer TD, Knibb JA, Xuereb JH, Hodges JR.

Neurology. 2007 Jan 16;68(3):238-9. No abstract available.

PMID:
17224582
20.

Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology.

Kersaitis C, Halliday GM, Xuereb JH, Pamphlett R, Bak TH, Hodges JR, Kril JJ.

Neuropathol Appl Neurobiol. 2006 Feb;32(1):83-91.

PMID:
16409556
21.

Clinical and pathological characterization of progressive aphasia.

Knibb JA, Xuereb JH, Patterson K, Hodges JR.

Ann Neurol. 2006 Jan;59(1):156-65.

PMID:
16374817
22.

Clinical, imaging and pathological correlates of a hereditary deficit in verb and action processing.

Bak TH, Yancopoulou D, Nestor PJ, Xuereb JH, Spillantini MG, Pulvermüller F, Hodges JR.

Brain. 2006 Feb;129(Pt 2):321-32. Epub 2005 Dec 5.

PMID:
16330501
23.

The pathological basis of semantic dementia.

Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH.

Brain. 2005 Sep;128(Pt 9):1984-95. Epub 2005 Jul 6.

PMID:
16000337
24.

Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia.

Yancopoulou D, Xuereb JH, Crowther RA, Hodges JR, Spillantini MG.

J Neuropathol Exp Neurol. 2005 Mar;64(3):245-53.

PMID:
15804056
25.

Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy.

Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S.

Brain. 2005 Mar;128(Pt 3):500-15. Epub 2005 Jan 19.

PMID:
15659428
26.

The human perirhinal cortex and semantic memory.

Davies RR, Graham KS, Xuereb JH, Williams GB, Hodges JR.

Eur J Neurosci. 2004 Nov;20(9):2441-6.

PMID:
15525284
27.

Clinicopathological correlates in frontotemporal dementia.

Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, Kril JJ, Halliday GM.

Ann Neurol. 2004 Sep;56(3):399-406.

PMID:
15349867
28.

Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study.

Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK, Lynch A, Xuereb JH, Fryer T, Guadagno JV, Warburton EA.

Stroke. 2004 Jul;35(7):1659-64. Epub 2004 May 20.

PMID:
15155970
29.

Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy.

Harkness KA, Coles A, Pohl U, Xuereb JH, Baron JC, Lennox GG.

Eur J Neurol. 2004 Jan;11(1):59-62.

PMID:
14692890
30.

Gene structure of the human metabotropic glutamate receptor 5 and functional analysis of its multiple promoters in neuroblastoma and astroglioma cells.

Corti C, Clarkson RW, Crepaldi L, Sala CF, Xuereb JH, Ferraguti F.

J Biol Chem. 2003 Aug 29;278(35):33105-19. Epub 2003 Jun 3.

31.

Identification and characterization of the promoter region of the GRM3 gene.

Corti C, Xuereb JH, Corsi M, Ferraguti F.

Biochem Biophys Res Commun. 2001 Aug 17;286(2):381-7.

PMID:
11500049
32.

Genomic organization of the human metabotropic glutamate receptor subtype 3.

Corti C, Sala CF, Yang F, Corsi M, Xuereb JH, Ferraguti F.

J Neurogenet. 2000 Dec;14(4):207-25, 271.

PMID:
11342382
33.
34.

Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.

Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, van Broeckhoven C, Morris CM.

Brain. 2000 Dec;123 Pt 12:2467-74.

PMID:
11099448
35.

Tau gene mutation K257T causes a tauopathy similar to Pick's disease.

Rizzini C, Goedert M, Hodges JR, Smith MJ, Jakes R, Hills R, Xuereb JH, Crowther RA, Spillantini MG.

J Neuropathol Exp Neurol. 2000 Nov;59(11):990-1001.

PMID:
11089577
36.

Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Mukaetova-Ladinska EB, Garcia-Siera F, Hurt J, Gertz HJ, Xuereb JH, Hills R, Brayne C, Huppert FA, Paykel ES, McGee M, Jakes R, Honer WG, Harrington CR, Wischik CM.

Am J Pathol. 2000 Aug;157(2):623-36.

37.

Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders.

Xuereb JH, Brayne C, Dufouil C, Gertz H, Wischik C, Harrington C, Mukaetova-Ladinska E, McGee MA, O'Sullivan A, O'Connor D, Paykel ES, Huppert FA.

Ann N Y Acad Sci. 2000 Apr;903:490-6.

PMID:
10818543
38.
39.

Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.

Mathuranath PS, Xuereb JH, Bak T, Hodges JR.

J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):304-12.

40.

Membrane instability, plasmalogen content, and Alzheimer's disease.

Ginsberg L, Xuereb JH, Gershfeld NL.

J Neurochem. 1998 Jun;70(6):2533-8.

41.

Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.

Irving RM, Harada T, Moffat DA, Hardy DG, Whittaker JL, Xuereb JH, Maher ER.

Am J Otol. 1997 Nov;18(6):754-60.

PMID:
9391673
42.

A molecular, clinical, and immunohistochemical study of vestibular schwannoma.

Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Holland FJ, Maher ER.

Otolaryngol Head Neck Surg. 1997 Apr;116(4):426-30.

PMID:
9141389
43.

The messenger RNAs for the N-methyl-D-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain.

Rigby M, Le Bourdellès B, Heavens RP, Kelly S, Smith D, Butler A, Hammans R, Hills R, Xuereb JH, Hill RG, Whiting PJ, Sirinathsinghji DJ.

Neuroscience. 1996 Jul;73(2):429-47.

PMID:
8783260
44.

Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.

Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH, O'Connor DW, Paykel ES.

Dementia. 1996 May-Jun;7(3):169-74. Review.

PMID:
8740632
45.

Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.

Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, Maher ER.

J Neurosurg. 1996 May;84(5):847-51.

PMID:
8622160
46.

The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample.

Gertz HJ, Xuereb JH, Huppert FA, Brayne C, Krüger H, McGee MA, Paykel ES, Harrington CR, Mukaetova-Ladinska EB, O'Connor DW, Wischik CM.

Eur Arch Psychiatry Clin Neurosci. 1996;246(3):132-6.

PMID:
8739398
47.

Neuropathological diagnosis and CAG repeat expansion in Huntington's disease.

Xuereb JH, MacMillan JC, Snell R, Davies P, Harper PS.

J Neurol Neurosurg Psychiatry. 1996 Jan;60(1):78-81.

48.

Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia.

Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM.

Neurosci Lett. 1995 Dec 29;202(1-2):101-4.

PMID:
8787841
49.

Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain.

Ginsberg L, Rafique S, Xuereb JH, Rapoport SI, Gershfeld NL.

Brain Res. 1995 Nov 6;698(1-2):223-6.

PMID:
8581486
50.

Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease.

Lai RY, Gertz HN, Wischik DJ, Xuereb JH, Mukaetova-Ladinska EB, Harrington CR, Edwards PC, Mena R, Paykel ES, Brayne C, et al.

Neurobiol Aging. 1995 May-Jun;16(3):433-45.

PMID:
7566351

Supplemental Content

Loading ...
Support Center